LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2017 - 2026)
Powered by 
Analysis
LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -71.56% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 15.51% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 68.09% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 34.84% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -95.71% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 16.91% |
| 10 | LivaNova | 4.51 Bn | 3.99 Bn | 273.67 Mn | 90.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.02% |
| Mar 31, 2026 | 57.27% |
| Dec 31, 2025 | 67.02% |
| Sep 30, 2025 | 121.65% |
| Jun 30, 2025 | 40.33% |
| Mar 31, 2025 | 211.14% |
| Dec 31, 2024 | 141.68% |
| Sep 30, 2024 | 654.08% |
| Jun 30, 2024 | 120.40% |
| Mar 31, 2024 | 686.48% |
| Dec 31, 2023 | -639.11% |
| Sep 30, 2023 | 102.85% |
| Jun 30, 2023 | -46.84% |
| Mar 31, 2023 | -114.38% |
| Dec 31, 2022 | -73.22% |
| Sep 30, 2022 | -820.74% |
| Jun 30, 2022 | 200.52% |
| Mar 31, 2022 | 439.07% |
| Dec 31, 2021 | 124.44% |
| Sep 30, 2021 | 380.99% |